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Abstract
Introduction: Sweat test has a diagnostic role in evaluation of cystic fibrosis. Its performance includes sweat stimulation, collection and analysis. 
All listed may be sources of inconsistencies in everyday practice. The aim of this study was an evaluation of external quality assessment (EQA) of swe-
at chloride measurement including sweat test performance in medical biochemistry laboratories in Croatia.
Materials and methods: EQA for sweat chloride measurement was provided by Croatian Centre for Quality Assessment in Laboratory Medicine 
(CROQALM) in five consecutive exercises to medical biochemistry laboratories (MBL) that offered sweat testing. A questionnaire regarding all phases 
of testing was mailed to involved MBL (N = 10). Survey results were compared to current guidelines for sweat test performance.
Results: Reported results of EQA in 2015 exercises showed coefficients of variation (CV) from 28.9%, 29.0% to 35.3%, respectively. An introduction 
of uniform sweat chloride measurement protocol resulted in CV of 15.5% and 14.7% reported in following two exercises in 2016. All MBL included in 
this study replied to the questionnaire. Results reported by MBL indicated: lack of patient information policy (7/10), use of unacceptable electrodes 
(6/9), misuse of minimum of acceptable sweat weight (6/9), lack of internal quality assessment (5/9) and recommended reference ranges (5/9 and 
4/9). Agreements to guidelines were found in approach to unsuitable patients (9/10) and sweat collection (8/9).
Conclusion: Presented results indicate major weak points of current practice in sweat test performance in Croatian MBL and stress the need for its 
standardization on a national level. 
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Introduction
It was six decades ago since Gibson and Cook in-
troduced sweat testing in clinical practice for diag-
nosis of cystic fibrosis (CF) (1). It is an inherited, life-
shortening disease mostly presented by dysfunc-
tion of gastrointestinal and respiratory organs 
caused by mutation of Cystic Fibrosis Transmem-
brane Conductance Regulator (CFTR) gene (2). 
CFTR gene regulates translation of CFTR protein, 
ubiquitous membrane regulator presented also on 
epithelium of sweat glands and involved in trans-
port of chloride, sodium and water (3). CF incidence 
and prevalence vary across Europe, but a median 
incidence is around 1:3500 and a mean prevalence 
of 0.737 per 10,000 indicating that prevalence is 
less than 5 per 10,000 and classifying CF in rare or 
“orphan disease” (4,5). Demographic data of CF in 
Croatia (south-east Europe, population of 4,290 
000 roughly, birth rate around 39,000 per annum) 
are rather poor giving an estimated number of 
around 110 individuals affected by disease (6,7).
The sweat test is three steps procedure including 
sweat gland stimulation, sweat collection and 
chloride measurement. Through decades sweat 
test evolved in variety of techniques for sweat 
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stimulation, collection and analysis, but a basic 
principle of sweat gland stimulation by pilocar-
pine iontophoresis (PI) remained unchanged. Cur-
rently there are two accepted techniques for sweat 
stimulation and collection in the clinical settings: 
Gibson and Cook technique (GCT) and Wescor 
Macroduct collection system (8,9). The latter is a 
commercial set while GCT includes verified set of 
devices and materials according to international 
official regulation for PI (9). Both of them require 
manual work and extensive skills in the perfor-
mance. According to current guidelines the ac-
ceptable method for sweat chloride measurement 
can be any of listed: coulometry, indirect ion selec-
tive electrode (ISE), mercurimetric titration (Schales 
and Schales micro method) if is validated (8,9). Ex-
ternal quality assessment data indicate domina-
tion of coulometry over indirect ISE or titration 
(10). Recently, an inductively coupled plasma mass 
spectrometry was reported as a promising meth-
od for sweat chloride quantification (11). Guide-
lines approved methods take part of sweat testing 
intended for diagnosis of CF. In clinical practice 
was also adopted the sweat conductometry meth-
od that used PI for sweat glands stimulation but 
measured conductivity (concentration and mobili-
ty) of chloride and all other ions in sweat (8). Due 
to its lower diagnostic accuracy than sweat test, 
the sweat conductometry was given role of 
screening test for CF (9). 
Croatian national guideline for CF diagnosis and 
management is in line with the international 
standards giving a diagnostic role to sweat test in 
CF clinical pathway (12). In era of published inter-
national sweat test performance guidelines it 
seems that inconsistencies in carrying out a sweat 
test are still present in everyday practice (13,14). 
Considering published reports about real-life 
sweat test challenges, a question about national 
sweat test practice emerged in light of related 
data lack. It prompted the Croatian Centre for 
Quality Assessment in Laboratory Medicine (CRO-
QALM) to introduce in 2015 the Sweat test scheme 
as a pilot for screening a current practice of that 
test in Croatia (15). The CROQALM is a national pro-
vider of external quality assessment (EQA) for all 
registered medical biochemistry laboratories 
(MBL) in Croatia. Participation in all schemes ex-
cept pilots is mandatory for all MBL according to 
policy of the Croatian Chamber of Medical Bio-
chemist (16). The Sweat test scheme has been cov-
ering only the analytical phase of the test and data 
collected in 2015 show unacceptable analytical 
outcomes with large data dispersions. It called for 
an urgent action and raised questions about other 
topics in sweat test performance. All together it 
made a path to survey about real-life sweat test 
practice in Croatia with the final goal to detect crit-
ical points of sweat test procedure. 
Materials and methods
In 2015, the CROQALM database registered 196 
MBL, eight of them (8/196; 4%) performed sweat 
chloride measurement by mercurimetric titration. 
In 2016 one more MBL participated in sweat test 
scheme (9/198; 5%). During 2015 and 2016 one 
MBL offered sweat conductometry which results 
were not included in EQA evaluation but that MBL 
took part in the survey. Finally, total number of 
MBL participated with results in sweat test scheme 
was 8 in 2015 and 9 in 2016 but total number of 
survey participants was 10. In the first exercise 
(June 2015) one control sample (liquid ready to 
use) for sweat test scheme was delivered by mail 
(written instruction included) to all MBL registered 
in CROQALM database. In September 2015 exer-
cise as well as in all following CROQALM rounds, 
control sample was distributed only to MBL re-
porting sweat chloride result in previous scheme. 
Participating laboratories reported data on-line by 
the link on CROQALM website.
Reported results from two exercises (June and 
September) in 2015 were far from acceptable. Con-
sidering those poor data, we asked sweat test 
scheme participating MBL to send to CROQALM 
their written protocols for the chloride measure-
ment in sweat. Comparing received protocols 
from eight MBL we found many inconsistencies in 
relation to the original Schales and Schales micro 
method, the protocol for sweat chloride mercuri-
metic titration (17). Therefore, sweat test team pre-
pared a uniform protocol in accordance to above 
listed method and mailed it with a questionnaire 
in the first 2016 exercise (March 2016) to all MBL 
participating in sweat test scheme including MBL 
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that performed sweat conductometry. Beside 
three previously listed exercises, sweat test 
scheme participated in two additional CROQALM 
exercises in November 2015 and June 2016.
The questionnaire was mailed in second exercise 
2016 (May 2016) to all MBL offering sweat test. It 
encompassed MBL participating in sweat test 
scheme and one MBL offering sweat test conduc-
tometry. Total number of involved MBL was ten.
Mailed questionnaire was redesigned and en-
larged version of similar set of questions that had 
been used by the Working group for external 
body fluids of CSMBLM in 2015 survey. Data re-
garding sweat test collected in that study had nev-
er been published due to poor response rate of 
the participated Croatian MBL (18).  
The questionnaire comprised of 18 questions (Q1-
Q18) intending to provide data on key points of 
sweat test performance (pre-analytical, analytical 
and post-analytical phases). Questionnaire was de-
signed with multiple choices of responses and a 
possibility to specify an answer. Additional request 
a photo of the electrodes that participants use for 
sweat stimulation was also mailed. Total of 16 
questions referred to contents of internationally 
accepted guidelines. The other two questions (Q3, 
Q9) had local features due to informal and unpub-
lished data about real-life sweat test practice in 
Croatia. Participation in the survey was voluntary 
and the results were coded.
The control sample for CROQALM sweat testing 
scheme is “in house” chloride solution prepared 
just prior to each CROQALM exercise in the Clinical 
Institute of Laboratory Diagnostics, University 
Hospital Centre Rijeka according to protocol for in-
ternal quality control (8). Results of sweat test 
scheme were evaluated using inlab2*QALM soft-
ware (IN2 Group Ltd., Zagreb, Croatia), specifically 
designed in 2011 for quality evaluation of medical 
laboratory performances. Outliers were excluded 
manually for results 40% below or above of the all 
participants group mean.




In 2015 results of chloride measurements by mercu-
rimetric titration had been received from eight MBL 
but in 2016 one more MBL was introduced in sweat 
test scheme. In conclusion total of 9 MBL were in-
cluded in CROQALM sweat test scheme in 2016. 
In five CROQALM exercises (2015-2016), mean and 
median chloride concentrations in control sam-
ples ranged from normal (< 30 mmol/L) to inter-
mediate (< 60 mmol/L) levels regarding chloride 
reference ranges in sweat. In 2015 reported data 
from MBL extended from normal to positive rang-
es (> 60 mmol/L) with coefficients of variation 
CROQALM exercises N
Chloride concentrations in control samples






Before uniform protocol introduction
1st (June 2015) 8 53.0 ± 15.0 51.5 (36.3 – 128.0) 28.9 0
2nd(September 2015) 8 25.5 ± 7.4 23.9 (16.0 – 36.0) 29.0 1
3rd (November 2015) 8 45.4 ± 16.1 52.8 (22.5 – 64.6) 35.3 3
After uniform protocol introduction
1st (March 2016) 8 29.7 ± 4.6 28.5 (24.8 – 37.0) 15.5 0
2nd (June 2016) 9 21.5 ± 3.2 19.9 (18.0 – 26.0) 14.7 2
N – Number of participating laboratories. SD - standard deviation. CV – coefficient of variation.
Table 1. Results of Croatian Centre for Quality Assessment in Laboratory Medicine (CROQALM) exercises in chloride concentrations 
of the sweat test scheme
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from 28.9% to 35.3%. An introduction of uniform 
sweat chloride mercurimetic titration protocol for 
all MBL involved in Sweat test scheme resulted in 
reported coefficients of variation from 14.7 to 
15.5% in next two exercises in 2016 (Table 1).
Survey
The response rate on survey was maximal in sense 
that all involved MBL (N = 10) replied (Table 2), but 
passed over the request about sending electrodes 
photos. They were collected by an addition request 
to all involved MBL during the third CROQALM exer-
cise in 2016. One MBL that performed sweat con-
ductometry responded on 10 out of 18 questions 
(Q1-Q8, Q13 and Q15). All of them addressed prean-
alytical phase of sweat testing that is common to 
two previously listed sweat test varieties. On Q8 
one MBL replied with a comment but without an an-
swer. On Q16 and Q13 response rates were 8/9 and 
9/10 MBL. On Q14 participants specified as follows: 
“in house” quality control used three of nine and 
commercial urine quality control used two of nine 
MBL. One specification on Q14 was invalid because it 
included an external quality control in use. Detailed 
responses stratified by each participating MBL and 
corresponding questions are presented in Table 3. 
Table 2. Questionnaire of sweat test performance in Croatian medical biochemistry laboratories.
Questions N/TN





Q2: Where do you perform sweat stimulation and collection? 10/10
a) in a clinic 4
b) in a laboratory 6
Q3: What method do you use for sweat stimulation? 10/10
a) pilocarpine iontophoresis 10
b) wrapping a patient with plastic material 0
Q4: Who performs sweat stimulation and collection? 10/10
a) laboratory technician and/or technologist 5
b) medical biochemist 1
c) clinical staff 4
Q5: What type of information do you provide to parents or patients about sweat test? 10/10
a) only written 0
b) only verbal 5
c) verbal and written 2
d) by hospital web site 1
e) no information provided 2
Q6: Do you test new-borns less than 2 weeks of age? 10/10
a) yes 2
b) no 8
Q7: Do you test new-borns less than 3 kg of weight? 10/10
a) yes 1
b) no 9
Biochemia Medica 2017;27(1):122–30   http://doi.org/10.11613/BM.2017.016 
126
Aralica M, Lenicek Krleza J. Evaluation of sweat testing in Croatia
Q8: Number of additional sweat tests carried out after first positive result? 10/10
a) 1 4
b) 2 5
c) > 3 0
Q9: Which electrodes do you use for sweat stimulation? 9/9
a) stainless steel electrodes 0
b) cooper electrodes 3
c) electrodes of flexible size and curvature made by local manufacturer 6
d) electrodes of unspecified origin 0
Q10: How long do you collect sweat after pilocarpine iontophoresis? 9/9
a) < 30 min 1
b) 30 min 8
c) 30 - 40 min 0
d) > 40 min 0
Q11: What is the minimum acceptable sweat weight for chloride analysis? 9/9
a) 50 mg 1
b) 75 mg 5
c) 100 mg 2
d) no criteria for acceptable sweat weight 1
e) other, specify 0
Q12: What do you use for sweat collection? 9/9
a) pre-weighed gauze 7
b) pre-weighed filter paper 2
c) polypropylene or glass tube 0
Q13: What do you do when insufficient sweat weight is collected? 9/10
a) keep testing and carry out chloride analysis 1
b) stop testing and repeat sweat collection another time 7
c) carry out bilateral sweat collection 1
Q14: Do you use internal quality control? 9/9
a) yes, specify 5
b) no 4
Q15: What is the number of sweat test performed annually by the most involved individual staff? 10/10
a) ≤ 10 0
b) 11 - 49 4
c) ≥ 50 5
d) no record 1
Q16: What are your laboratory reference ranges for sweat chloride in infants < 6 months of age? 8/9
a) negative < 30 mmol/L; intermediate 30 - 60 mmol/L; positive > 60 mmol/L 3
b) negative < 60 mmol/L; intermediate 60 - 80 mmol/L; positive > 80 mmol/L 3
c) other, specify 2
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Q17: What are your laboratory reference ranges for sweat chloride in infants > 6 months of age and adults? 9/9
a) negative < 40 mmol/L; intermediate 40 - 60 mmol/L; positive > 60 mmol/L 5
b) negative < 60 mmol/L; intermediate 60 - 80 mmol/L; positive > 80 mmol/L 1
c) other, specify 3
Q18: Is collected sweat weight included in the laboratory sweat test report? 9/9
a) yes, specify 3
b) no 6
N – number of responders. TN – total number of participating laboratories.
 MBL Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Q14a Q15 Q16 Q17 Q18
1 d a a c c b b b c b c a b a A c b a a
2 c b a a b a a NR c b b a b a B c b b a
3 c b a a c b b b b b b b b a B b a a b
4 b a a c e b b b c a a a b b - b NR c b
5 b b a a b b b a c b b a b a B b a a b
6 a b a b b b b a c b d a NR b - d c c b
7 a a a c e b b b c b b a a b - b b a a
8 d b a a b a b b b b b b b a A c c c b
9 b a a c d b b a b b c a c b C c a a b
10* c b a a b b b a NA NA NA NA b NA NA c NA NA NA
MBL- medical biochemistry laboratory. Q1 - Q18 – questions defined in Table 2. NR - no response. NA - not applicable. A - urine 
commercial control. B – “in-house” control. C - external quality control. *MBL performed sweat conductometry;
Table 3. Stratified responses of medical biochemistry laboratory in national questionnaire.
Comments on the survey 
Q1, Q2, Q4, Q5, Q15 – Number of 50 sweat tests per 
annum had been suggested as minimum number 
of testing for laboratory performing sweat test 
(19). An annual number of sweat tests more than 
50 ensures that involved centre is qualified in this 
challenging performance. Furthermore, there is a 
request of minimum testing for individual staff 
member per annum. In the survey, majority of 
MBL (8/10) reported more tests per annum that 
recommended, but two MBL did not meet that re-
quest. One of them was in line with other eight 
MBL regarding number of reported individual staff 
sweat testing per annum. In four centres (4/10) 
sweat stimulation and collection was performed 
in a clinic by clinical stuff exclusively. It seems a 
common practice across Europe that sweat stimu-
lation and collection are settled in a clinic and a 
laboratory (13,14). Regarding patient information, 
current guidelines recommend that the centre 
should provide written or audio/visual material to 
patients and parents attending the test (8,9). This 
practice reported three out of ten MBL in the sur-
vey. Furthermore, two out of ten centres provided 
no information to parents and patients about 
sweat testing.
Q3 – All MBL (10/10) stated the PI as a method for 
sweat stimulation. It was in accordance with cur-
rent guidelines that exclusively recognised PI as 
method of choice (8,9). 
Q6, Q7 – Patients suitability address feasibility of 
their physiological and clinical state for sweat test. 
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It was reported that patient weight and age had 
great impact on success of PI (20). Current guide-
lines discourage sweat testing in new-borns hav-
ing less than 2 weeks of age and 2-3 kilograms of 
weight. Majority of surveyed MBL were in accord-
ance with recommendations regarding new-borns 
age (8/10) and weight (9/10).
Q8 – According to reports in all MBL (10/10) the 
first positive sweat test result called for one or two 
more testing for CF diagnosis. It is in accordance 
with international and national clinical guidelines 
(8,12). Although sweat test is a gold standard for 
CF there is common practice of repeating sweat 
testing in case of the first positive result (9). Sweat 
test repeating practice makes reported result 
more confident for CF but it should be always in-
terpreted in context of patient presentation, famil-
iar background genetic testing and new-born 
screening if the latter is available (8). Although 
sweat test has superior diagnostic accuracy to ge-
netic testing and equal role in official CF diagnos-
tic pathway in real-life clinical practice retesting 
patients with initially positive result commonly 
precede molecular testing (3,12). However positive 
sweat test may be considered in other clinical con-
ditions not related to CF. Regarding sweat test 
positive result it is worth to mention that chloride 
concentration above 160 mmol/L is not linked 
with human physiology and it is rather an indica-
tor of poor test performance (9).
Q9 – Current guidelines recommend use of stain-
less steel or copper electrodes for the PI. They 
should be suitable and fixed size with an extra de-
vice that allows stable and safe application on pa-
tient flexor surface of forearm (8,9). Six out of nine 
MBL reported use of electrodes produced by local 
manufacturer (Figure 1). Those electrodes did not 
meet guidelines criteria for fixed size due to their 
design as bracelet of flexible length that is adjust-
able around patient forearm since size depends of 
his/her age. Such electrodes design excludes con-
trolled sweat stimulation. It refers particularly to 
unfixed size of stimulated area and uncontrolled 
sweat secretion rate that compromises accurate 
minimum sweat weight acceptable for analysis 
and increases a possibility of false chloride con-
centration in report.
Q10 – The sweat collection more than 30 minutes 
is not supported by guidelines due to fact that the 
most intensive sweating occurs 10 to 30 minutes 
after stimulation (8,9). Surveyed MBL declared cor-
rect practice in rate 8 out of 9.
Q11, Q13, Q18 – The minimum acceptable sweat 
weight (MASW) is defined as sweat weight pro-
duced by secretion rate > 1 g/m2/minute and col-
lected after stimulation (8). MASW is highly de-
pended of stimulation area (electrode and filter/
gauze size), sweat secretion rate, collection time 
and patient suitability including age, weight, race 
and skin condition (8,9). At low sweat rate < 1 g/m2/
minute, sweat production is limited contributing to 
false decrease chloride concentration (21). Correct 
set-up of MASW is a cornerstone of sweat testing 
limiting occurrence of false results (9). In the sur-
vey, almost all MBL (8/9) reported MASW use on 
different levels ranging from 50 to 100 mg but five 
of them used electrodes made by local manufac-
turer that excluded a rationale for MASW. However 
most of MBL (7/9) performed the correct action in 
managing insufficient sweat quantity to stop the 
test and repeat it another time. An importance of 
sweat weight for correct interpretation of sweat 
result was recognised by its inclusion in sweat re-
port (19). Such practice reported 3 out of 9 MBL.
Q12 – The pre-weighed filter paper or gauze are 
acceptable devices for sweat stimulation and col-
lection if they fit by size and origin (low content of 
Figure 1. Electrodes for pilocarpine iontophoresis (PI) pro-
duced by local manufacturer
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chloride). Majority of MBL (7/9) preferred pre-
weighed gauze over pre-weighed filter paper.
Q14 – Internal quality control (IQC) for sweat test is 
mandatory part of quality assurance and it is 
strongly recommended by guidelines. IQC in-
cludes commercial and/or “in house” controls (8,9). 
Five out of nine MBL introduced IQC as part of 
quality assessment. The types of IQC in use were 
“in house” controls or commercial urine controls. 
Chloride concentrations levels in commercial urine 
controls typically range from 50 to 150 mmol/L 
and correspond to chloride intermediate to high 
concentrations in sweat but low levels (30 - 40 
mmol/L) important for clinical decision remained 
out of quality assessment.
Q16, Q17 – Current guidelines recommend two 
levels of sweat chloride reference ranges depend-
ing on patient’s age. Only 3 out of 8 MBL stated 
correct reference ranges for infants aged 6 months 
or less while results of reported use of reference 
ranges for older infants and adults were better 
and included 5 out of 8 MBL. 
Discussion
Sweat chloride measurement is a part of schemes 
of several external quality assessment providers 
(10,22,23). EQA, together with internal quality con-
trol (IQC) is an optimal tool for monitoring analyti-
cal phase of testing. Although all of them must be 
part of sweat test performance in clinical laborato-
ries, our results reveal lack of internal quality as-
sessment in some Croatian MBL and previously 
published Italian sweat test survey stressed low 
access of laboratories in external quality assess-
ment (13). One of possible obstacles for Croatian 
MBL may be limited selection of methods for eval-
uation offered by providers of commercial quality 
controls nevertheless an “in-house” IQC is allowed 
by current guidelines. Listed selection mainly in-
cludes coulometry or ISE, but almost all Croatian 
MBL offer mercurimetric titration. According to 
guidelines it is acceptable method for sweat chlo-
ride analysis, but it should be verified to insure reli-
ability of reported results. In the field of laboratory 
medicine, verification process commonly follows 
standardisation. Lack of standardisation is main 
drawback in 2015 CROQALM exercises presenting 
poor chloride measurement of involved MBL. It 
was made up with introduction of uniform proto-
col resulting in better data obtained in following 
exercises. Such standard less practice may com-
promise quality of testing and have negative im-
pact on clinical decision. External quality control 
assessment is an optimal way to find out inconsist-
encies in testing and making corrections as was 
proved in our study. Furthermore, it is also an edu-
cational process with the final goal to permanently 
improve testing in clinical laboratories (24).
External quality control focused only on sweat 
chloride measurement gives an insight to the ana-
lytical phase of the testing but excludes an assess-
ment of sweat stimulation, collection and report-
ing results. Common way to check up on those is-
sues is use of comprehensive questionnaire based 
on current sweat test performance guidelines.
A design of presented questionnaire was partially 
made in accordance to outdated UK guideline from 
2003 (19). It is particularly addressed to Q1 and Q18. 
Authors believed that an annual number of sweat 
testing (Q1) may give a clear picture of sweat test 
workload in one MBL as well as inclusion of sweat 
weight on report (Q18) may provide an extra infor-
mation about accuracy of sweat test performance. 
Therefore, questionnaire also included all relevant 
topics from updated UK and CLSI guidelines (8,9). 
In addition, it brings up some potentially useful 
data about use of unverified devices and raises the 
concern about accuracy of PI performance in Croa-
tian MBL. From presented data low adherence to 
current guidelines in areas of patient information, 
PI performance, quality assessment and report of 
sweat chloride reference ranges are evident. The 
latter is extremely important for proper clinical de-
cision and evaluation of results.
However, it seems that inconsistencies of different 
origin are common practice in real-life sweat test-
ing across the globe. Our study is in line with re-
cently published studies that revealed several are-
as of concerns ranging from patients’ information, 
internal and external quality assessment to the use 
of appropriate reference ranges despite of interna-
tionally accepted guidelines that made a path to 
standardised performance of sweat test (13,14,25).
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In conclusion, results of this survey pointed out a 
need for standardisation of sweat test practice in 
Croatian MBL.
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